METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2
Xianjian Wu(Affiliated Hospital of Youjiang Medical University for Nationalities), Jian Pu(Affiliated Hospital of Youjiang Medical University for Nationalities)
Cited by 10
Related Papers
Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling
|Cell Death and Disease|2022|76
Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages
|Cell Death and Disease|2021|28
ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis
|Frontiers in Oncology|2021|23
<scp>N<sup>6</sup></scp>‐methyladenosine‐modified <scp>FAM111A‐DT</scp> promotes hepatocellular carcinoma growth via epigenetically activating <scp>FAM111A</scp>
|Cancer Science|2023|18
HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way
|Molecular Medicine Reports|2023|4